Anthem Inc.

Symbol: ANTM     Sector: Healthcare     Industry: Health Care Plans

Dividend Yield
1.05%
Current Price
$303.97
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 09:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
-
24,666,000,000
-
-
-
-
1,551,000,000
-
74,523,000,000
44,525,000,000
29,998,000,000
4,482,000,000
1,946,000,000
-
19,342,000,000
549,000,000
1,630,000,000
 
-

Financials 2018

Update: 2019-06-10 09:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
-
23,373,000,000
-
-
-
-
425,000,000
-
71,571,000,000
43,030,000,000
28,541,000,000
3,934,000,000
1,994,000,000
-
19,211,000,000
-325,000,000
463,000,000
 
-

Q 3

2018-09-30
-
23,251,000,000
-
-
-
-
960,000,000
-
74,445,000,000
45,351,000,000
29,094,000,000
4,260,000,000
2,119,000,000
-
19,419,000,000
-421,500,000
606,900,000
 
-

Q 2

2018-06-30
-
22,943,700,000
-
-
-
-
1,053,400,000
-
74,367,400,000
45,642,400,000
28,725,000,000
4,682,000,000
1,770,200,000
-
19,285,600,000
51,500,000
542,100,000
 
-

Q 1

2018-03-31
-
22,537,500,000
-
-
-
-
1,312,500,000
-
73,300,400,000
46,288,000,000
27,012,400,000
4,630,600,000
1,775,800,000
-
19,885,900,000
1,021,300,000
2,214,900,000
 
-

Financials 2017

Update: 2019-06-10 09:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
-
22,680,400,000
-
-
-
-
1,230,800,000
-
70,540,000,000
44,037,100,000
26,502,900,000
3,608,900,000
2,549,600,000
-
19,931,800,000
-2,488,700,000
-1,301,200,000
 
-